Literature DB >> 31413086

Masked polycythemia vera: analysis of a single center cohort of 2480 red cell masses.

Nabih Maslah1,2,3,4, Juliette Soret2,5, Christine Dosquet1,2,4, Laetitia Vercellino6, Célia Belkhodja1,2, Marie-Hélène Schlageter1,2,4, Bruno Cassinat1,2,4, Jean-Jacques Kiladjian2,3,4,5, Christine Chomienne1,2,3,4, Stephane Giraudier7,2,3,4.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31413086      PMCID： PMC7049378          DOI： 10.3324/haematol.2018.215582

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  Inapparent polycythemia vera: an unrecognized diagnosis.

Authors:  T Lamy; A Devillers; M Bernard; A Moisan; I Grulois; B Drenou; L Amiot; R Fauchet; P Y Le Prise
Journal:  Am J Med       Date:  1997-01       Impact factor: 4.965

2.  Classification of myeloproliferative disorders in the JAK2 era: is there a role for red cell mass?

Authors:  B Cassinat; C Laguillier; C Gardin; V de Beco; S Burcheri; P Fenaux; C Chomienne; J-J Kiladjian
Journal:  Leukemia       Date:  2007-08-23       Impact factor: 11.528

Review 3.  Rethinking the diagnostic criteria of polycythemia vera.

Authors:  T Barbui; J Thiele; A M Vannucchi; A Tefferi
Journal:  Leukemia       Date:  2013-12-19       Impact factor: 11.528

4.  Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology.

Authors:  T C Pearson; D L Guthrie; J Simpson; S Chinn; G Barosi; A Ferrant; S M Lewis; Y Najean
Journal:  Br J Haematol       Date:  1995-04       Impact factor: 6.998

5.  Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis.

Authors:  Richard T Silver; William Chow; Attilio Orazi; Stephen P Arles; Stanley J Goldsmith
Journal:  Blood       Date:  2013-07-30       Impact factor: 22.113

6.  European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia.

Authors:  Hans Michael Kvasnicka; Attilio Orazi; Juergen Thiele; Giovanni Barosi; Carlos E Bueso-Ramos; Alessandro M Vannucchi; Robert P Hasserjian; Jean-Jacques Kiladjian; Umberto Gianelli; Richard Silver; Tariq I Mughal; Tiziano Barbui
Journal:  Am J Hematol       Date:  2017-07-29       Impact factor: 10.047

7.  Initial (latent) polycythemia vera with thrombocytosis mimicking essential thrombocythemia.

Authors:  Jurgen Thiele; Hans Michael Kvasnicka; Volker Diehl
Journal:  Acta Haematol       Date:  2005       Impact factor: 2.195

Review 8.  Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.

Authors:  Jasper H Smalberg; Lidia R Arends; Dominique C Valla; Jean-Jacques Kiladjian; Harry L A Janssen; Frank W G Leebeek
Journal:  Blood       Date:  2012-10-04       Impact factor: 22.113

Review 9.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

Review 10.  The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.

Authors:  Tiziano Barbui; Jürgen Thiele; Heinz Gisslinger; Hans Michael Kvasnicka; Alessandro M Vannucchi; Paola Guglielmelli; Attilio Orazi; Ayalew Tefferi
Journal:  Blood Cancer J       Date:  2018-02-09       Impact factor: 11.037
View more
  5 in total

1.  Time for revival of the red blood cell count and red cell mass in the differential diagnosis between essential thrombocythemia and polycythemia vera?

Authors:  Hans Carl Hasselbalch
Journal:  Haematologica       Date:  2019-11       Impact factor: 9.941

Review 2.  Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms.

Authors:  Alexandre Guy; Johanne Poisson; Chloe James
Journal:  Leukemia       Date:  2021-03-03       Impact factor: 11.528

Review 3.  Clinical insights into the origins of thrombosis in myeloproliferative neoplasms.

Authors:  Alison R Moliterno; Yelena Z Ginzburg; Ronald Hoffman
Journal:  Blood       Date:  2021-03-04       Impact factor: 22.113

4.  Anemia and hemodilution: analysis of a single center cohort based on 2,858 red cell mass measurements.

Authors:  Louis Drevon; Nabih Maslah; Juliette Soret-Dulphy; Christine Dosquet; Odno Ravdan; Laetitia Vercellino; Celia Belkhodja; Nathalie Parquet; Anne C Brignier; Marie-Helene Schlageter; Bruno Cassinat; Jean-Jacques Kiladjian; Christine Chomienne; Stéphane Giraudier
Journal:  Haematologica       Date:  2021-04-01       Impact factor: 9.941

5.  Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients.

Authors:  Giuseppe G Loscocco; Paola Guglielmelli; Naseema Gangat; Elena Rossi; Carmela Mannarelli; Silvia Betti; Chiara Maccari; Francesco Ramundo; Yamna Jadoon; Francesca Gesullo; Sara Ceglie; Chiara Paoli; Animesh Pardanani; Valerio De Stefano; Ayalew Tefferi; Alessandro M Vannucchi
Journal:  Am J Hematol       Date:  2021-09-06       Impact factor: 13.265
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.